Please provide your email address to receive an email when new articles are posted on . A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, ...
Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
Subcutaneous sumatriptan 6 mg is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan because of unpleasant or unwanted side effects. To evaluate ...
Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology Presentation at the 2nd Annual Drug ...
The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults. The FDA has approved sumatriptan nasal spray (Tosymra) for the acute ...
NEW YORK Results from two clinical studies presented at this year’s American Headache Society meeting could help a needle-free migraine drug from Zogenix get Food and Drug Administration approval. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback